Literature DB >> 6874583

Bu-2470, a new peptide antibiotic complex. I. Production, isolation and properties of Bu-2470 A, B1 and B2.

M Konishi, K Sugawara, K Tomita, K Matsumoto, T Miyaki, K Fujisawa, H Tsukiura, H Kawaguchi.   

Abstract

A strain of Bacillus circulans produced a complex of basic peptide antibiotics designated Bu-2470, which was found to contain four active components, A, B1, B2a and B2b. Bu-2470 A specifically inhibited various Pseudomonas species including P. aeruginosa, P. maltophilia and P. putida, but otherwise its antibacterial spectrum was limited to certain Gram-negative organisms. Bu-2470 B1 and B2 (B2a + B2b) showed broad antibiotic activity against Gram-positive and Gram-negative bacteria including Pseudomonas species. The physicochemical and biological properties of Bu-2470 B1 and B2 are very similar to those of the octapeptin group of antibiotics.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874583     DOI: 10.7164/antibiotics.36.625

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

Review 1.  Rediscovering the octapeptins.

Authors:  Tony Velkov; Kade D Roberts; Jian Li
Journal:  Nat Prod Rep       Date:  2017-03-17       Impact factor: 13.423

2.  Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes.

Authors:  Mei-Ling Han; Hsin-Hui Shen; Karl A Hansford; Elena K Schneider; Sivashangarie Sivanesan; Kade D Roberts; Philip E Thompson; Anton P Le Brun; Yan Zhu; Marc-Antoine Sani; Frances Separovic; Mark A T Blaskovich; Mark A Baker; Samuel M Moskowitz; Matthew A Cooper; Jian Li; Tony Velkov
Journal:  ACS Infect Dis       Date:  2017-07-11       Impact factor: 5.084

3.  Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.

Authors:  Chao-Dong Qian; Xue-Chang Wu; Yi Teng; Wen-Peng Zhao; Ou Li; Sheng-Guo Fang; Zhao-Hui Huang; Hai-Chun Gao
Journal:  Antimicrob Agents Chemother       Date:  2011-12-19       Impact factor: 5.191

4.  Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria.

Authors:  Bernd Becker; Mark S Butler; Karl A Hansford; Alejandra Gallardo-Godoy; Alysha G Elliott; Johnny X Huang; David J Edwards; Mark A T Blaskovich; Matthew A Cooper
Journal:  Bioorg Med Chem Lett       Date:  2017-04-12       Impact factor: 2.823

5.  Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.

Authors:  Elena K Schneider-Futschik; Olivia K A Paulin; Daniel Hoyer; Kade D Roberts; James Ziogas; Mark A Baker; John Karas; Jian Li; Tony Velkov
Journal:  ACS Infect Dis       Date:  2018-04-02       Impact factor: 5.084

6.  Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.

Authors:  Jessica L Chitty; Mark S Butler; Azzah Suboh; David J Edwards; Matthew A Cooper; James A Fraser; Avril A B Robertson
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.